Abstract
Tuberculin is still the only available skin test reagent for the diagnosis of mycobacterial infection. The product has a remarkable sensitivity, but poor specificity. Previous studies, including two human phase I clinical trials, have indicated that rdESAT-6 has a potential as an improved skin test reagent. Animal studies have shown that the sensitivity may be increased by inclusion of the genetically related CFP-10 antigen in the preparation without loosing specificity.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | P L o S One |
| Vol/bind | 5 |
| Udgave nummer | 6 |
| Sider (fra-til) | e11277 |
| ISSN | 1932-6203 |
| DOI | |
| Status | Udgivet - 1 jan. 2010 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS